SCHEMBL18301162

SCHEMBL18301162

N#CCn1ccc2cc(Cl)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.54
▸ HTR2C P28335 1/20 0.54
▸ CDK4 P11802 1/20 0.45
▸ CCND1 P24385 1/20 0.45
▸ PRMT5 O14744 1/20 0.43
▸ OXER1 Q8TDS5 1/20 0.39
▸ APP P05067 1/20 0.39
▸ KMO O15229 1/20 0.39
▸ KRAS P01116 2/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ ACLY P53396 2/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730350 0.86 KMO (0.53) HTR2AHTR2CPRMT5OXER1APP
Ethoxycarbonyl Group SCHEMBL28746661 0.84 HTR2A (0.44) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL8128124 0.83 HTR2A (0.51) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL18856961 0.80 HTR2A (0.58) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL18301155 0.79 HTR2A (0.54) HTR2AHTR2CPRMT5APPKRAS
SCHEMBL6726048 0.77 HTR2A (0.63) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL6087507 0.75 HDAC8 (0.57) HTR2AHTR2CCDK4CCND1APP
SCHEMBL23956140 0.75 HTR7 (0.62) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL31525736 0.74 PLA2G4A (0.46) APPHDAC3HDAC1HDAC2HDAC8
SCHEMBL4705937 0.74 CDK4 (0.61) HTR2AHTR2CCDK4CCND1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307724-A1 SELECTIVE ANTI-CANCER COMPOUNDS National University of Singapore (SG) 2018-04-18 — — EP disclosed
WO-2016200339-A1 SELECTIVE ANTI-CANCER COMPOUNDS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-12-15 — — WO disclosed
Send feedback